Clinical Trials Logo

Clinical Trial Summary

Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. It has been reported that those children fall frequently so the purpose of this study is to investigate the effectiveness of balance and coordination training in these Children.


Clinical Trial Description

The effects of physical exercise training interventions for childhood cancer participants are not yet convincing due to small numbers of participants and insufficient study methodology. More and high-quality evidence is needed in order to be able to draft exercise and physical activity guidelines for this population. Despite the positive results of exercise interventions in adult cancer patients, the evidence for benefits in childhood cancer patients is limited. There are Two Main objectives: 1. To investigate the effectiveness of Pilates core stability exercises program. 2. To investigate the effectiveness of Humac balance and tilt system. Secondary Objectives: 1. The effectiveness of coordination training in children with posterior fossa tumors. 2. The comparison between balance and coordination training and which of both trainings has more effect. This study will take place in a pediatric oncology setting, Children's Cancer Hospital Egypt(CCHE), in outpatient setting. Patients will be evaluated for their balance and coordination at initial presentation, during treatment, and during follow-up after end of treatment at CCHE. Also patients will receive balance and coordination training, before each chemotherapy cycle-maximum one week- given the patient is in good state. Sixty children with posterior fossa tumors of both sexes will participate in this study. They will be selected from CCHE. They will be randomly assigned into 3 groups of equal number. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04528316
Study type Interventional
Source Children's Cancer Hospital Egypt 57357
Contact
Status Completed
Phase N/A
Start date August 6, 2020
Completion date April 30, 2021

See also
  Status Clinical Trial Phase
Terminated NCT04167618 - 177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma Phase 1/Phase 2
Active, not recruiting NCT03288168 - Children's and Adolescents' Medulloblastoma Molecular Subgroups in China
Recruiting NCT05298995 - GD2-CAR T Cells for Pediatric Brain Tumours Phase 1
Recruiting NCT04174820 - Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition
Completed NCT04860934 - Dual Task Training On Children With Ataxia After Medulloblastoma Resection N/A
Suspended NCT03904862 - Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery Phase 1/Phase 2
Withdrawn NCT01697514 - A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma Phase 1
Recruiting NCT05230758 - Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour Phase 3
Not yet recruiting NCT05406947 - Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
Completed NCT02238899 - Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma N/A
Recruiting NCT05057702 - Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma N/A
Recruiting NCT04185038 - Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors Phase 1
Terminated NCT02624388 - Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) Phase 2